Ceftriaxone-resistant viridans streptococci bacteraemia among patients treated at a large comprehensive cancer care centre: a retrospective eighteen-year study.

Autor: Marsland P; Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6420, USA., Jain R; Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6420, USA.; Department of Pharmacy, University of Washington, 1959 NE Pacific St. HSB H-375, Seattle, WA 98195-7630, USA., Tverdek F; Department of Pharmacy, University of Washington, 1959 NE Pacific St. HSB H-375, Seattle, WA 98195-7630, USA.; Antimicrobial Stewardship Program, Fred Hutchinson Cancer Center, 825 Eastlake Ave. E, PO Box 19023, Seattle, WA 98109-1023, USA., Hendrie P; Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6420, USA., Liu C; Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6420, USA.; Antimicrobial Stewardship Program, Fred Hutchinson Cancer Center, 825 Eastlake Ave. E, PO Box 19023, Seattle, WA 98109-1023, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., P.0. Box 19024, Seattle, WA 98109-1024, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., P.0. Box 19024, Seattle, WA 98109-1024, USA.; Infection Prevention, Fred Hutchinson Cancer Center, 825 Eastlake Ave. E, PO Box 19023, Seattle, WA 98109-1023, USA., Pergam SA; Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6420, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., P.0. Box 19024, Seattle, WA 98109-1024, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., P.0. Box 19024, Seattle, WA 98109-1024, USA.; Infection Prevention, Fred Hutchinson Cancer Center, 825 Eastlake Ave. E, PO Box 19023, Seattle, WA 98109-1023, USA., Bourassa L; Department of Laboratory Medicine and Pathology, University of Washington, 1959 NE Pacific St., Box 357470, Seattle, WA 98195-7470, USA.

Publikováno v: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2024 Aug 05; Vol. 6 (4), pp. dlae126. Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).

Cluster of Nontoxigenic Corynebacterium diphtheriae Infective Endocarditis and Rising Background C. diphtheriae Cases-Seattle, Washington, 2020-2023.

Autor: Karmarkar EN; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Fitzpatrick T; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Himmelfarb ST; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Chow EJ; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.; Communicable Disease Epidemiology and Immunization Section, Public Health-Seattle & King County, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Smith HZ; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Lan KF; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Matsumoto J; Department of Laboratory Medicine and Pathology, University of Washington and Harborview Medical Center, Seattle, Washington, USA., Graff NR; Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, Washington, USA., DeBolt C; Center for Public Health Medical and Veterinary Science, Washington State Department of Health, Shoreline, Washington, USA., Truong T; Department of Laboratory Medicine and Pathology, University of Washington and Harborview Medical Center, Seattle, Washington, USA., Bourassa L; Department of Laboratory Medicine and Pathology, University of Washington and Harborview Medical Center, Seattle, Washington, USA., Farquhar C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Fang FC; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington and Harborview Medical Center, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Kim HN; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Pottinger PS; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 May 15; Vol. 78 (5), pp. 1214-1221.

Evaluation of Fourier transform-infrared spectroscopy (FT-IR) as a control measure for nosocomial outbreak investigations.

Autor: Uribe G; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Salipante SJ; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Curtis L; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Lieberman JA; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Kurosawa K; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Cookson BT; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Hoogestraat D; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Stewart MK; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA., Olmstead T; Department of Psychiatry and Behavioral Sciences, University of New Mexico , Albuquerque, New Mexico, USA., Bourassa L; Department of Laboratory Medicine and Pathology, University of Washington , Seattle, Washington, USA.

Publikováno v: Journal of clinical microbiology [J Clin Microbiol] 2023 Oct 24; Vol. 61 (10), pp. e0034723. Date of Electronic Publication: 2023 Oct 03.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States.

Autor: Asempa TE; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT. Electronic address: Tomefa.asempa@hhchealth.org., Bobenchik AM; Department of Pathology, Division of Clinical Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA., Bourassa L; Division of Microbiology, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA., Clark AE; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX., Hatch MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Huse HK; Department of Pathology, Harbor-UCLA Medical Center, Torrance, CA., Martin IW; Department of Pathology and Laboratory Medicine, Dartmouth Health, Lebanon, NH., Mochon AB; Banner Health, Phoenix, AZ; Sonora Quest Laboratories, Phoenix, AZ; Department of Pathology, University of Arizona College of Medicine, Phoenix, AZ., Munson E; Department of Medical Laboratory Science, Marquette University, Milwaukee, WI., Sfeir MM; Department of Pathology and Laboratory Medicine, University of Connecticut Health Center, Farmington, CT., Srodon M; Department of Pathology, Eastern Connecticut Health Network, Manchester, CT., Wang Y; Cape Regional Health System, Cape May Court House, NJ., Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT; Division of Infectious Diseases, Hartford Hospital, Hartford, CT.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2023 Mar; Vol. 61 (3), pp. 106733. Date of Electronic Publication: 2023 Jan 20.